Influence of polymer addition on the amorphization, dissolution and physical stability of co-amorphous systems

被引:33
|
作者
Liu, Jingwen [1 ]
Grohganz, Holger [1 ]
Rades, Thomas [1 ]
机构
[1] Univ Copenhagen, Dept Pharm, Univ Pk 2, DK-2100 Copenhagen, Denmark
关键词
Co-amorphous; Polymer; Amorphization; Molecular interaction; Dissolution; Physical stability; SOLID DISPERSIONS; DRUG-DELIVERY; AMINO-ACIDS; IN-VITRO; BEHAVIOR; CRYSTALLIZATION; STATE; STABILIZATION; FORMERS;
D O I
10.1016/j.ijpharm.2020.119768
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Co-amorphous systems have been developed to address the solubility challenge of poorly-water soluble drugs. However, the dissolution rate of co-amorphous systems can be too fast in some cases, causing super-saturation, followed by precipitation and thereafter loss of the advantage. In this study, hydroxypropyl methylcellulose (HPMC) was co-formulated at 10% (w/w) with carvedilol-L-aspartic acid (CAR-ASP) co-amorphous systems at CAR to ASP molar ratios of 1:1, 1:1.5 and 1:2. No obvious changes of glass transition temperatures (T(g)s) were detected for CAR-ASP 1:1.5-HPMC and CAR-ASP 1:2-HPMC compared to the corresponding co-amorphous systems, whilst CAR-ASP 1:1-HPMC showed an increased T-g (88.9 +/- 1.3 degrees C) compared to CAR-ASP 1:1 (80.2 +/- 0.9 degrees C). HPMC was involved in the molecular interactions of the CAR-ASP-HPMC systems, but did not disturb ionic interactions between CAR and ASP. Addition of HPMC optimized the dissolution of the CAR-ASP systems by reducing the initial dissolution rate and maintaining super-saturation for a longer period. No negative effect of HPMC addition on physical stability was observed at 25 degrees C and 40 degrees C under dry conditions for 7 months. Therefore, it appears promising to co-formulate a small amount of polymer with co-amorphous systems to achieve optimized dissolution characteristics while maintaining the desired physical stability.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] "Aging" in co-amorphous systems: Dissolution decrease and non-negligible dissolution increase during storage without recrystallization
    Shen, Luyan
    Liu, Xianzhi
    Wu, Wencheng
    Zhou, Lin
    Liang, Guang
    Wang, Yi
    Wu, Wenqi
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2024, 667
  • [42] How can we improve the physical stability of co-amorphous system containing flutamide and bicalutamide? The case of ternary amorphous solid dispersions
    Pacult, Justyna
    Rams-Baron, Marzena
    Chmiel, Krzysztof
    Jurkiewicz, Karolina
    Antosik, Agata
    Szafraniec, Joanna
    Kurek, Mateusz
    Jachowicz, Renata
    Paluch, Marian
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 136
  • [43] Co-amorphous systems using epigallocatechin-3-gallate as a co-former: Stability, in vitro dissolution, in vivo bioavailability and underlying molecular mechanisms
    Chen, Jinfeng
    Li, Huaning
    Li, Xiangwei
    Yuan, Dandan
    Cheng, Hongqing
    Ke, Yixin
    Cheng, Jianming
    Wang, Zengwu
    Chen, Jing
    Li, Junsong
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2022, 178 : 82 - 93
  • [44] Co-Amorphous Combination of Nateglinide-Metformin Hydrochloride for Dissolution Enhancement
    Wairkar, Sarika
    Gaud, Ram
    AAPS PHARMSCITECH, 2016, 17 (03): : 673 - 681
  • [45] Stoichiometric-dependent physical stability of atorvastatin-lisinopril co-amorphous in stress testing
    Shu, Yecheng
    Jia, Jirun
    Zhao, Peixu
    Bao, Rui
    Li, Wen
    Yang, Li
    Tang, Xing
    He, Zhonggui
    Fu, Qiang
    JOURNAL OF INDUSTRIAL AND ENGINEERING CHEMISTRY, 2024, 139 : 175 - 184
  • [46] Deaggregation and Crystallization Inhibition by Small Amount of Polymer Addition for a Co-Amorphous Curcumin-Magnolol System
    Han, Jiawei
    Li, Luyuan
    Su, Meiling
    Heng, Weili
    Wei, Yuanfeng
    Gao, Yuan
    Qian, Shuai
    PHARMACEUTICS, 2021, 13 (10)
  • [47] Preparation of Co-Amorphous Systems by Freeze-Drying
    Wostry, Melvin
    Plappert, Hanna
    Grohganz, Holger
    PHARMACEUTICS, 2020, 12 (10) : 1 - 12
  • [48] Influence of variation in molar ratio on co-amorphous drug-amino acid systems
    Jensen, Katrine Tarp
    Larsen, Flemming Hofmann
    Lobmann, Korbinian
    Rades, Thomas
    Grohganz, Holger
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2016, 107 : 32 - 39
  • [49] Mechanistic Investigation into Crystallization of Hydrated Co-Amorphous Systems of Flurbiprofen and Lidocaine
    Xu, Xiaoyue
    Grohganz, Holger
    Knapik-Kowalczuk, Justyna
    Paluch, Marian
    Rades, Thomas
    PHARMACEUTICS, 2025, 17 (02)
  • [50] Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Challenging Case of Lumefantrine-PAA
    Yao, Xin
    Kim, Soojin
    Gui, Yue
    Chen, Zhenxuan
    Yu, Junguang
    Jones, Karen J.
    Yu, Lian
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2021, 110 (11) : 3670 - 3677